KT Knight Therapeutics Inc. Stock: price and directors' dealings · Canada · SEDISource id SEDI:knight-therapeutics-inc CA · SEDI Mcap CA$964.6M Follow the Knight Therapeutics Inc. share price and the full management transaction log of the company, a listed issuer based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €964.6m. The latest transaction was disclosed on 15 July 2026 (51 - Exercise of options). Among the most active insiders: Groleau, Melanie. Every trade is free.
Analyst consensus: bullish or bearish? Analysts rate Knight Therapeutics Inc. Strong Buy (bullish), based on 7 analysts. Average price target: CA$10.83.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,757 of 29,062 companies
FCF yld 3.8%
Earn yld -0.6%
EV/EBITDA 16.7x
ROE 1.9%
Gross mgn 44%
Net mgn -1.2%
Debt/EBITDA 1.3x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 July 2026
All Executives43 Thresholds0 Prospectus0 Other0
Declarations 43 total
◇ 5 - Senior Officer of Issuer · Executives · 13 Jul 2026
8,066 shares @ CA$7.75 0.0065% mcap 14.9% of flow Common Shares SEDI:4752576 ◇ 5 - Senior Officer of Issuer · Executives · 13 Jul 2026
45,054 shares @ CA$7.75 0.036% mcap 83.2% of flow Options SEDI:4752573 ● 5 - Senior Officer of Issuer · Executives · 6 Jul 2026
8,035 shares @ CA$9.85 0.0080% mcap 17.2% of flow Restricted Share Unit SEDI:4749579 ● 5 - Senior Officer of Issuer · Executives · 6 Jul 2026
Restricted Share Unit SEDI:4749575 ● 5 - Senior Officer of Issuer · Executives · 6 Jul 2026
16,069 shares @ CA$9.85 0.016% mcap 34.5% of flow Performance stock Unit SEDI:4749573 ● 5 - Senior Officer of Issuer · Executives · 6 Jul 2026
Performance stock Unit SEDI:4749566 ◇ 5 - Senior Officer of Issuer · Executives · 6 Jul 2026
22,540 shares @ CA$9.85 0.023% mcap 48.3% of flow Options SEDI:4749564 ● 5 - Senior Officer of Issuer · Executives · 6 Jul 2026
▲ 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
200 shares @ CA$5.22 0.0001% mcap 12.3% of flow Common Shares SEDI:4736915 Canonical exit: 13 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
794 shares @ CA$9.36 0.0008% mcap 100.0% of flow Common Shares SEDI:4736914 Canonical exit: 13 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
140 shares @ CA$5.22 0.0001% mcap 100.0% of flow Common Shares SEDI:4736912 Canonical exit: 13 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
720 shares @ CA$5.22 0.0004% mcap 17.2% of flow Common Shares SEDI:4736911 Canonical exit: 13 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
1,934 shares @ CA$9.36 0.0019% mcap 82.8% of flow Common Shares SEDI:4736910 Canonical exit: 13 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
361 shares @ CA$5.22 0.0002% mcap 18.7% of flow Common Shares SEDI:4736909 Canonical exit: 13 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
876 shares @ CA$9.36 0.0008% mcap 81.3% of flow Common Shares SEDI:4736908 Canonical exit: 13 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder · Executives · 15 Jun 2026
267 shares @ CA$5.22 0.0001% mcap 17.2% of flow Common Shares SEDI:4736907 Canonical exit: 13 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder · Executives · 15 Jun 2026
718 shares @ CA$9.36 0.0007% mcap 82.8% of flow Common Shares SEDI:4736906 Canonical exit: 13 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
296 shares @ CA$5.22 0.0002% mcap 19.2% of flow Common Shares SEDI:4736905 Canonical exit: 13 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
695 shares @ CA$9.36 0.0007% mcap 80.8% of flow Common Shares SEDI:4736904 Canonical exit: 13 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
593 shares @ CA$5.22 0.0003% mcap 29.9% of flow Common Shares SEDI:4736903 Canonical exit: 13 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 15 Jun 2026
774 shares @ CA$9.36 0.0007% mcap 70.1% of flow Common Shares SEDI:4736902 Canonical exit: 13 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Jun 2026
29,403 shares @ CA$9.25 0.028% mcap 23.7% of flow Common Shares SEDI:4733907 Canonical exit: 8 Sept 2026 (T+90) ◇ 5 - Senior Officer of Issuer · Executives · 10 Jun 2026
29,403 shares @ CA$7.73 0.024% mcap 19.8% of flow Common Shares SEDI:4733902 ◇ 5 - Senior Officer of Issuer · Executives · 10 Jun 2026
29,403 shares @ CA$7.73 0.024% mcap 19.8% of flow Options SEDI:4733895 ▲ 5 - Senior Officer of Issuer · Executives · 10 Jun 2026
5,129 shares @ CA$9.25 0.0049% mcap 4.1% of flow Common Shares SEDI:4733880 Canonical exit: 8 Sept 2026 (T+90) 25 of 43 declarations
Load more (18 remaining) 关于 Knight Therapeutics Inc. Knight Therapeutics Inc. 是一家加拿大制药公司，专注于为加拿大和国际市场收购和开发药物。该公司在多伦多证券交易所上市，股票代码为 KNT。